A 20-year experience with nocardiosis in solid organ transplant (SOT) recipients in the Southwestern United States: A single-center study

被引:39
作者
Majeed, Aneela [1 ]
Beatty, Norman [1 ]
Iftikhar, Ahmad [2 ]
Mushtaq, Adeela [2 ]
Fisher, Julia [3 ]
Gaynor, Pryce [4 ]
Kim, Jeeyong C. [4 ]
Marquez, Jose L. [5 ]
Mora, Francisco E. [5 ]
Georgescu, Anca [1 ]
Zangeneh, Tirdad [1 ]
机构
[1] Univ Arizona, Div Infect Dis, Dept Med, Tucson, AZ 85721 USA
[2] Univ Arizona, Dept Med, Div Hematol & Oncol, Tucson, AZ USA
[3] Univ Arizona, Inst BIO5, Stat Consulting Lab, Tucson, AZ USA
[4] Univ Arizona, Coll Med, Tucson, AZ USA
[5] Univ Arizona, Dept Med, Tucson, AZ USA
关键词
cytomegalovirus; immunosuppression; nocardia; risk factors; solid organ transplant; TMP; SMX prophylaxis; INFECTION; IDENTIFICATION; AUSTRALIA; DATABASE; HOST;
D O I
10.1111/tid.12904
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BackgroundNocardiosis is a life-threatening opportunistic infection. Solid organ transplant (SOT) recipients are at higher risk (incidence 0.04%-3.5%) of developing nocardiosis. Rate of nocardiosis in the Southwestern US may be high due to environmental factors. MethodsWe performed a retrospective review study on 54 SOT patients diagnosed with Nocardia between 1997 and 2016 at our center. To explore the association of various risk factors with both the development of disseminated disease and mortality, a series of Fisher's exact tests was used. FindingsIncidence of nocardiosis in SOT patients was 2.65%. Fisher's exact tests revealed no association between development of disseminated disease and the following variables: transplant rejection (P=1), elevated tacrolimus levels (P=.4), and CMV viremia (P=.06). Also, we did not find any association between mortality and the variables we evaluated: type of transplant, transplant rejection, renal failure, disseminated nocardia, and patient's age. Overall mortality and 1-year mortality were 17% and 11%. InterpretationBased on our findings, daily 1 DS TMP/SMX prophylaxis did not appear to provide reliable protection against nocardiosis. However, we could not state definitely that TMP/SMX prophylaxis was or wasn't protective because of lack control group. None of the Fisher's exact tests revealed associations between the tested risk factors and either disease dissemination or mortality. This could be due to a true lack of association between the variables in each pair. However, it is also likely that our relatively small sample size limited our power to detect underlying relationships that may be present. Compared with other studies, 1-year mortality was lower at our institution (11% vs 16%).
引用
收藏
页数:9
相关论文
共 21 条
[1]   Nocardiosis: Updated Clinical Review and Experience at a Tertiary Center [J].
Ambrosioni, J. ;
Lew, D. ;
Garbino, J. .
INFECTION, 2010, 38 (02) :89-97
[2]   NOCARDIOSIS IN RENAL-TRANSPLANT RECIPIENTS UNDERGOING IMMUNOSUPPRESSION WITH CYCLOSPORINE [J].
ARDUINO, RC ;
JOHNSON, PC ;
MIRANDA, AG .
CLINICAL INFECTIOUS DISEASES, 1993, 16 (04) :505-512
[3]   NOCARDIA SPECIES - HOST-PARASITE RELATIONSHIPS [J].
BEAMAN, BL ;
BEAMAN, L .
CLINICAL MICROBIOLOGY REVIEWS, 1994, 7 (02) :213-264
[4]   Evaluation of partial 16S ribosomal DNA sequencing for idefitification of Nocardia species by using the MicroSeq 500 system with an expanded database [J].
Cloud, JL ;
Conville, PS ;
Croft, A ;
Harmsen, D ;
Witebsky, FG ;
Carroll, KC .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (02) :578-584
[5]  
Cooper CJ, 2014, INFECT DIS REP, V6, P9, DOI [10.4081/idr.20145327, 10.4081/idr.2014.5327]
[6]   Nocardia Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study [J].
Coussement, Julien ;
Lebeaux, David ;
van Delden, Christian ;
Guillot, Helene ;
Freund, Romain ;
Marbus, Sierk ;
Melica, Giovanna ;
Van Wijngaerden, Eric ;
Douvry, Benoit ;
Van Laecke, Steven ;
Vuotto, Fanny ;
Tricot, Leila ;
Fernandez-Ruiz, Mario ;
Dantal, Jacques ;
Hirzel, Cedric ;
Jais, Jean-Philippe ;
Rodriguez-Nava, Veronica ;
Lortholary, Olivier ;
Jacobs, Frederique .
CLINICAL INFECTIOUS DISEASES, 2016, 63 (03) :338-345
[7]   Nocardiosis in persons with human immunodeficiency virus infection, transplant recipients, and large, geographically defined populations [J].
Filice, GA .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2005, 145 (03) :156-162
[8]   NOCARDIOSIS IN LIVER-TRANSPLANTATION - VARIATION IN PRESENTATION, DIAGNOSIS AND THERAPY [J].
FORBES, GM ;
HARVEY, FAH ;
PHILPOTTHOWARD, JN ;
OGRADY, JG ;
JENSEN, RD ;
SAHATHEVAN, M ;
CASEWELL, MW ;
WILLIAMS, R .
JOURNAL OF INFECTION, 1990, 20 (01) :11-19
[9]   Molecular actions of calcineurin inhibitors [J].
Hamawy, MM .
DRUG NEWS & PERSPECTIVES, 2003, 16 (05) :277-282
[10]   Nocardia infection in lung transplant recipients [J].
Husain, S ;
McCurry, K ;
Dauber, J ;
Singh, N ;
Kusne, S .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (03) :354-359